Lobular carcinoma in situ of the breast: Preliminary results of treatment by ipsilateral mastectomy and contralateral breast biopsy
โ Scribed by Paul Peter Rosen; David W. Braun Jr.; Barbara Lyngholm; Jerome A. Urban; David W. Kinne
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 617 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Lobular carcinoma in situ (LCIS) of the breast is commonly identified as an incidental finding in breast biopsies performed because of either a mammographic abnormality or a palpable mass. Although long recognized as an entity, the significance and optimal treatment of LCIS remains controversial. In
A review of 3299 benign breast lesions was carried out. Lobular carcinoma in sifu (LCIs) was discovered in 52 cases; and of these, 44 had been treated by biopsy alone. During the follow-up period averaging 15.9 years, 1 1 patients developed invasive breast cancer (IBC): 9 ipsilateral lesions, and 4
## Eighteen-Year Results in the Treatment of Early Breast Carcinoma with Mastectomy Versus Breast Conservation Therapy W e applaud the recent report by Poggi et al. 1 regarding the 18-year follow-up data of the National Cancer Institute randomized trial on breast conservation therapy (BCT) versus
Ninety-eight women with lobular carcinoma in situ (LICS) of the breast were identified over a 16-year period. Consecutive slide review of all breast material over a 12-year period identified 25 women with LCIS o n biopsy who.did not undergo mastectomy. Only 1 woman (4%) in a complete followup averag